References
- McElroy SL, Keck PE Jr, Strakowski SM. An overview of the treatment of schizoaffective disorder. J Clin Psychiatry. 1999;60:16-22
- Glick ID, Murray SR, Vasudevan P, Marder SR, Hu RJ. (2001). Treatment with atypical antipsychotics: New indications and new populations. J Psychiatr Res. 2001;35:187-191.
- Grieger TA, Benedek DM, Flynn J. Pharmacologic treatment of patients hospitalized with the diagnosis of schizoaffective disorder. J Clin Psychiatry. 2001;62:59-60.
- American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, 4th ed. Washington, DC: APA;1994.
- Sajatovic M, Brescan DW, Perez et al. Quetiapine alone and added to a mood stabilizer for serious mood disorders. J Clin Psychiatry. 2001;62:728-732
- Susman VL. Clinical management of neuroleptic malignant syndrome. Psychiatr Q. 2001;72:325-336.
- Arvanitis LA, Miller BG. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biol Psychiatry. 1997;42:233-246.
- Borison RL, Arvanitis LA, Miller BG. ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, place-bo-bo-controlled trial in patients with schizophrenia. US SEROQUEL Study Group. J Clin Psychopharmacol. 1996;16:158-169.
- Meats P. Quetiapine (‘Seroquel’): an effective and well-tolerated atypical antipsychotic. Int J Psych Clin Pract. 1997;1:231-239.
- Dev V, Raniwalla J. Quetiapine: a review of its safety in the management of schizophrenia. Drug Saf. 2000;23:295-307.
- Goldstein JM. "Seroquel" (quetiapine fumarate) reduces hostility and aggression in patients with acute schizophrenia. Paper presented at: American Psychiatric Association 151st Annual Meeting; May 30-June 4, 1998; Toronto, Canada.
- Brooks JO III. Successful outcome using quetiapine in a case of treatment-resistant schizophrenia with assaultive behavior. Schizophr Res. 2001;50:133-134.